Celldex Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
/ 
Frequently asked questions
To buy Celldex Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Celldex Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Celldex Therapeutics Inc. is CLDX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Celldex Therapeutics Inc. has its primary listing on NASDAQ. You can trade Celldex Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Celldex Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Celldex Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Celldex Therapeutics Inc. or others.